Further studies are needed to elucidate the complex interplay between sex hormones and KCNMA1 in breast- and prostate cancer that is likely to be influenced by the type of regulatory ß-subunits of the BK channel, alternative splicing, the background of ER and/or AR status, and anti-hormone therapy. Here, KCNMA1 is linked to prostate carcinoma.